Kari Hemminki

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 88

Top Topics

Multiple Myeloma

Herpes Simplex Virus

Chronic Lymphocytic Leukemia

Top Venues

Cancer medicine

International journal of molecular sciences

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Kari Hemminki, Frantisek Zitricky, Asta Försti, Akseli E Hemminki
Survival in Elderly Ovarian Cancer Remains Challenging in the Nordic Countries. Cancers 16 (12) (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Mika Kontro, Bjorn Tore Gjertsen, Marianne Tang Severinsen, Gunnar Juliusson
Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century. Blood cancer journal 14 (1) (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Akseli E Hemminki
Survival in Elderly Ovarian Cancer Remains Challenging in the Nordic Countries. Cancers 16 (12) (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Otto Hemminki, Vaclav Liska, Akseli E Hemminki
Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients. Cancer medicine 13 (15) (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Raija Silvennoinen, Annette Juul Vangsted, Markus Hansson
Large differencies in age-specific survival in multiple myeloma in the nordic countries. Blood cancer journal 14 (1) (2024)
Frantisek Zitricky, Anni I Koskinen, Otto Hemminki, Asta Försti, Akseli E Hemminki, Kari Hemminki
Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century. Cancer medicine 13 (1) (2024)
Frantisek Zitricky, Anni I Koskinen, Otto Hemminki, Asta Försti, Akseli E Hemminki, Kari Hemminki
Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century. Cancer medicine (2024)
František Zitrick, Anni Koskinen, Vaclav Liska, Asta Försti, Akseli E Hemminki, Kari Hemminki
Major Improvement in Thyroid Cancer Survival of Elderly Patients in the Nordic Countries. European journal of endocrinology (2024)
Kari Hemminki, Frantisek Zitricky, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli E Hemminki, Otto Hemminki
Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis. Cancer medicine 13 (7) (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Mika Kontro, Bjorn Tore Gjertsen, Marianne Tang Severinsen, Gunnar Juliusson
Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century. Blood cancer journal 14 (1) (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Mika Kontro, Bjorn Tore Gjertsen, Marianne Tang Severinsen, Gunnar Juliusson
Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century. Blood cancer journal 14 (1) (2024)
Hauke Thomsen, Subhayan Chattopadhyay, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Roman Hájek, Göran Hallmans, Ulrika Pettersson-Kymmer, Florentin Späth, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance. Blood cancer journal 14 (1) (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Raija Silvennoinen, Annette Juul Vangsted, Markus Hansson
Large differencies in age-specific survival in multiple myeloma in the nordic countries. Blood cancer journal 14 (1) (2024)
Hauke Thomsen, Subhayan Chattopadhyay, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Roman Hájek, Göran Hallmans, Ulrika Pettersson-Kymmer, Florentin Späth, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance. Blood cancer journal 14 (1) (2024)
Kari Hemminki, Yasmeen Niazi, Ludmila Vodickova, Pavel Vodicka, Asta Försti
Genetic And Environmental Associations Of Nonspecific Chromosomal Aberrations. Mutagenesis (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Otto Hemminki, Vaclav Liska, Akseli E Hemminki
Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients. Cancer medicine 13 (15) (2024)
Frantisek Zitricky, Anni I Koskinen, Otto Hemminki, Asta Försti, Akseli E Hemminki, Kari Hemminki
Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century. Cancer medicine (2024)
Frantisek Zitricky, Anni I Koskinen, Otto Hemminki, Asta Försti, Akseli E Hemminki, Kari Hemminki
Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century. Cancer medicine (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Otto Hemminki, Vaclav Liska, Akseli E Hemminki
Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients. Cancer medicine 13 (15) (2024)
František Zitrický, Anni Koskinen, Vaclav Liska, Asta Försti, Akseli E Hemminki, Kari Hemminki
Major improvement in thyroid cancer survival of elderly patients in the Nordic countries. European journal of endocrinology 190 (3) (2024)
Kari Hemminki, Frantisek Zitricky, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli E Hemminki, Otto Hemminki
Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis. Cancer medicine 13 (7) (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Raija Silvennoinen, Annette Juul Vangsted, Markus Hansson
Large differencies in age-specific survival in multiple myeloma in the nordic countries. Blood cancer journal 14 (1) (2024)
Kari Hemminki, Filip Tichanek, Asta Försti, Otto Hemminki, Akseli E Hemminki
Survival in gastric and esophageal cancers in the Nordic countries through a half century. Cancer medicine (2023)
Kari Hemminki, Asta Försti, Vaclav Liska, Anna Kanerva, Otto Hemminki, Akseli E Hemminki
Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements. International journal of cancer 152 (9) (2023)
Filip Tichánek, Asta Försti, Otto Hemminki, Akseli E Hemminki, Kari Hemminki
Survival in Lung Cancer in the Nordic Countries Through A Half Century. Clinical epidemiology 15 (2023)
Filip Tichanek, Asta Försti, Akseli E Hemminki, Otto Hemminki, Kari Hemminki
Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century. Cancers 15 (10) (2023)
Filip Tichanek, Asta Försti, Otto Hemminki, Akseli Hemminki, Kari Hemminki
Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries. Obstetrics and gynecology international 2023 (2023)
Filip Tichanek, Asta Försti, Vaclv Liska, Otto Hemminki, Anni Koskinen, Akseli E Hemminki, Kari Hemminki
Early mortality critically impedes improvements in thyroid cancer survival through a half century. European journal of endocrinology 189 (3) (2023)
Kari Hemminki, Asta Försti, Vaclav Liska, Anna Kanerva, Otto Hemminki, Akseli E Hemminki
Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements. International journal of cancer 152 (9) (2023)
Filip Tichánek, Asta Försti, Vaclav Liska, Akseli E Hemminki, Kari Hemminki
Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century. Cancers 15 (3) (2023)
Antonio José Cabrera-Serrano, José Manuel Sánchez-Maldonado, Rob Ter Horst, Angelica Macauda, Paloma García-Martín, Yolanda Benavente, Stefano Landi, Alyssa Clay-Gilmour, Yasmeen Niazi, Blanca Espinet, Juan José Rodríguez Sevilla, Eva María Pérez, Rossana Maffei, Gonzalo Blanco, Matteo Giaccherini, James R Cerhan, Roberto Marasca, Miguel Angel López-Nevot, Tzu Chen-Liang, Hauke Thomsen, Irene Gámez, Daniele Campa, Victor Moreno, Silvia de Sanjosé, Rafael Marcos-Gragera, María García-Álvarez, Trinidad Dierssen-Sotos, Andrés Jerez, Aleksandra Butrym, Aaron D Norman, Mario Luppi, Susan L Slager, Kari Hemminki, Yang Li, Sonja I Berndt, Delphine Casabonne, Miguel Alcoceba, Anna Puiggros, Mihai G Netea, Asta Försti, Frederico Canzian, Juan Sainz
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression? International journal of molecular sciences 24 (9) (2023)
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Vaclav Liska, Akseli E Hemminki, Xinjun Li
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers. Cancers 15 (12) (2023)
Phanindra Babu Kasi, Venkata Ramana Mallela, Filip Ambrozkiewicz, Andriy V Trailin, Václav Liška, Kari Hemminki
Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances. International journal of molecular sciences 24 (9) (2023)
José Manuel Sánchez-Maldonado, Antonio José Cabrera-Serrano, Subhayan Chattopadhyay, Daniele Campa, María Del Pilar Garrido, Angelica Macauda, Rob Ter Horst, Andrés Jerez, Mihai G Netea, Yang Li, Kari Hemminki, Frederico Canzian, Asta Försti, Juan Sainz
GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis. International journal of molecular sciences 24 (7) (2023)
Filip Tichánek, Asta Försti, Akseli E Hemminki, Otto Hemminki, Kari Hemminki
Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements. Cancers 15 (17) (2023)
Kari Hemminki, Asta Försti, Vaclav Liska, Anna Kanerva, Otto Hemminki, Akseli E Hemminki
Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements. International journal of cancer 152 (9) (2023)
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Vaclav Liska, Akseli Hemminki, Xinjun Li
Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden. Cancer (2023)
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Vaclav Liska, Akseli E Hemminki, Xinjun Li
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers. Cancers 15 (12) (2023)
Kari Hemminki, Asta Försti, Vaclav Liska, Anna Kanerva, Otto Hemminki, Akseli E Hemminki
Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements. International journal of cancer 152 (9) (2023)
Esther Clavero, José Manuel Sánchez-Maldonado, Angelica Macauda, Rob Ter Horst, Belém Sampaio-Marques, Artur Jurczyszyn, Alyssa Clay-Gilmour, Angelika Stein, Michelle A T Hildebrandt, Niels Weinhold, Gabriele Buda, Ramón García-Sanz, Waldemar Tomczak, Ulla Birgitte Vogel, Andrés Jerez, Daria Zawirska, Marzena Wątek, Jonathan N Hofmann, Stefano Landi, John J Spinelli, Aleksandra Butrym, Abhishek Kumar, Joaquín Martínez-López, Sara Galimberti, María Eugenia Sarasquete, Edyta Subocz, Elżbieta Iskierka-Jazdzewska, Graham G Giles, Malwina Rybicka-Ramos, Marcin Kruszewski, Niels Abildgaard, Francisco García Verdejo, Pedro Sánchez Rovira, Miguel Inacio da Silva Filho, Katalin Kadar, Małgorzata Razny, Wendy Cozen, Matteo Pelosini, Manuel Jurado, Parveen Bhatti, Marek Dudzinski, Agnieszka Druzd-Sitek, Enrico Orciuolo, Yang Li, Aaron D Norman, Jan Maciej Zaucha, Rui Manuel Vieira Reis, Miroslaw Markiewicz, Juan José Rodríguez Sevilla, Vibeke Andersen, Krzysztof Jamroziak, Kari Hemminki, Sonja I Berndt, Vicent Rajkumar, Grzegorz Mazur, Shaji K Kumar, Paula Ludovico, Arnon Nagler, Stephen J Chanock, Charles Dumontet, Mitchell J Machiela, Judit Varkonyi, Nicola J Camp, Elad Ziv, Annette Juul Vangsted, Elizabeth E Brown, Daniele Campa, Celine M Vachon, Mihai G Netea, Frederico Canzian, Asta Försti, Juan Sainz
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization. International journal of molecular sciences 24 (10) (2023)
Antonio José Cabrera-Serrano, José Manuel Sánchez-Maldonado, Rob Ter Horst, Angelica Macauda, Paloma García-Martín, Yolanda Benavente, Stefano Landi, Alyssa Clay-Gilmour, Yasmeen Niazi, Blanca Espinet, Juan José Rodríguez Sevilla, Eva María Pérez, Rossana Maffei, Gonzalo Blanco, Matteo Giaccherini, James R Cerhan, Roberto Marasca, Miguel Angel López-Nevot, Tzu Chen-Liang, Hauke Thomsen, Irene Gámez, Daniele Campa, Victor Moreno, Silvia de Sanjosé, Rafael Marcos-Gragera, María García-Álvarez, Trinidad Dierssen-Sotos, Andrés Jerez, Aleksandra Butrym, Aaron D Norman, Mario Luppi, Susan L Slager, Kari Hemminki, Yang Li, Sonja I Berndt, Delphine Casabonne, Miguel Alcoceba, Anna Puiggros, Mihai G Netea, Asta Försti, Frederico Canzian, Juan Sainz
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression? International journal of molecular sciences 24 (9) (2023)
Kari Hemminki, Janne Hemminki, Asta Försti, Amit Sud
Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment. Leukemia (2023)
Phanindra Babu Kasi, Venkata Ramana Mallela, Filip Ambrozkiewicz, Andriy V Trailin, Václav Liška, Kari Hemminki
Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances. International journal of molecular sciences 24 (9) (2023)
Frantisek Zitricky, Asta Försti, Akseli E Hemminki, Otto Hemminki, Kari Hemminki
Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements. Cancers 15 (16) (2023)
Frantisek Zitricky, Asta Försti, Akseli E Hemminki, Kari Hemminki
Conditional survival in breast cancer up to 10 years in the Nordic countries. Cancer medicine (2023)
Filip Tichánek, Asta Försti, Vaclav Liska, Akseli E Hemminki, Kari Hemminki
Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century. Cancers 15 (3) (2023)
Filip Tichánek, Asta Försti, Otto Hemminki, Akseli E Hemminki, Kari Hemminki
Survival in Lung Cancer in the Nordic Countries Through A Half Century. Clinical epidemiology 15 (2023)
Esraa Ali, Andriy V Trailin, Filip Ambrozkiewicz, Václav Liška, Kari Hemminki
Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies. International journal of molecular sciences 23 (23) (2022)
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Vaclav Liska, Akseli E Hemminki, Xinjun Li
Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country. Cancers 14 (8) (2022)
Kari Hemminki, Asta Försti, Vaclav Liska, Anna Kanerva, Otto Hemminki, Akseli E Hemminki
Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements. International journal of cancer (2022)
Anni Koskinen, Otto Hemminki, Asta Försti, Kari Hemminki
Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century. PloS one 17 (5) (2022)
Yasmeen Niazi, Nagarajan Paramasivam, Joanna Blocka, Abhishek Kumar, Stefanie Huhn, Matthias Schlesner, Niels Weinhold, Rolf Sijmons, Mirjam De Jong, Brian Durie, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma. Cells 12 (1) (2022)
Kari Hemminki, Asta Försti, Otto Hemminki, Vaclav Liska, Akseli E Hemminki
Long-term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast. International journal of cancer 151 (2) (2022)
Yasmeen Niazi, Nagarajan Paramasivam, Joanna Blocka, Abhishek Kumar, Stefanie Huhn, Matthias Schlesner, Niels Weinhold, Rolf Sijmons, Mirjam De Jong, Brian Durie, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma. Cells 12 (1) (2022)
Esraa Ali, Andriy V Trailin, Filip Ambrozkiewicz, Václav Liška, Kari Hemminki
Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies. International journal of molecular sciences 23 (23) (2022)
Yasmeen Niazi, Nagarajan Paramasivam, Joanna Blocka, Abhishek Kumar, Stefanie Huhn, Matthias Schlesner, Niels Weinhold, Rolf Sijmons, Mirjam De Jong, Brian Durie, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma. Cells 12 (1) (2022)
Kari Hemminki, Asta Försti, Vaclav Liska, Anna Kanerva, Otto Hemminki, Akseli E Hemminki
LONG-TERM SURVIVAL TRENDS IN SOLID CANCERS IN THE NORDIC COUNTRIES MARKING TIMING OF IMPROVEMENTS. International journal of cancer (2022)
Marie Rajtmajerová, Andriy V Trailin, Václav Liška, Kari Hemminki, Filip Ambrozkiewicz
Long Non-Coding RNA and microRNA Interplay in Colorectal Cancer and Their Effect on the Tumor Microenvironment. Cancers 14 (21) (2022)
Lizhen Zhu, Beiping Miao, Dagmara Dymerska, Magdalena Kuswik, Elena Bueno-Martínez, Lara Sanoguera-Miralles, Eladio A Velasco, Nagarajan Paramasivam, Matthias Schlesner, Abhishek Kumar, Ying Yuan, Jan A Lubiński, Obul Reddy Bandapalli, Kari Hemminki, Asta Försti
Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer. Cancers 14 (3) (2022)
Kari Hemminki, Asta Försti
Incidence, Mortality and Survival Trends in Breast Cancers Coincident with Introduction of Mammography in the Nordic Countries. Cancers 14 (23) (2022)
Kari Hemminki, Janne Hemminki, Asta Försti, Amit Sud
Survival trends in hematological malignancies in the Nordic countries through 50 years. Blood cancer journal 12 (11) (2022)
Yasmeen Niazi, Nagarajan Paramasivam, Joanna Blocka, Abhishek Kumar, Stefanie Huhn, Matthias Schlesner, Niels Weinhold, Rolf Sijmons, Mirjam De Jong, Brian Durie, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma. Cells 12 (1) (2022)
Kari Hemminki, Asta Försti
Incidence, Mortality and Survival Trends in Breast Cancers Coincident with Introduction of Mammography in the Nordic Countries. Cancers 14 (23) (2022)
Esraa Ali, Andriy V Trailin, Filip Ambrozkiewicz, Václav Liška, Kari Hemminki
Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies. International journal of molecular sciences 23 (23) (2022)
Kari Hemminki, Asta Försti
Incidence, Mortality and Survival Trends in Breast Cancers Coincident with Introduction of Mammography in the Nordic Countries. Cancers 14 (23) (2022)
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Vaclav Liska, Akseli E Hemminki, Xinjun Li
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers. International journal of cancer (2022)
Esraa Ali, Andriy V Trailin, Filip Ambrozkiewicz, Václav Liška, Kari Hemminki
Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies. International journal of molecular sciences 23 (23) (2022)
Beiping Miao, Diamanto Skopelitou, Aayushi Srivastava, Sara Giangiobbe, Dagmara Dymerska, Nagarajan Paramasivam, Abhishek Kumar, Magdalena Kuświk, Wojciech Kluźniak, Katarzyna Paszkowska-Szczur, Matthias Schlesner, Jan A Lubiński, Kari Hemminki, Asta Försti, Obul Reddy Bandapalli
Whole-Exome Sequencing Identifies a Novel Germline Variant in PTK7 Gene in Familial Colorectal Cancer. International journal of molecular sciences 23 (3) (2022)
Kari Hemminki, Filip Tichanek, Asta Försti, Otto Hemminki, Vaclav Liska, Akseli E Hemminki
Long-term incidence in hepatocellular carcinoma and intrahepatic bile duct cancer in Denmark, Finland, Norway and Sweden, role of Thorotrast? International journal of cancer 151 (4) (2022)
Andriy V Trailin, Lenka Červenková, Filip Ambrozkiewicz, Esraa Ali, Phanindra Kasi, Richard Pálek, Petr Hošek, Vladislav Třeška, Ondřej Daum, Zbynek Tonar, Václav Liška, Kari Hemminki
T- and B-Cells in the Inner Invasive Margin of Hepatocellular Carcinoma after Resection Associate with Favorable Prognosis. Cancers 14 (3) (2022)
Kari Hemminki, Asta Försti, Akseli Hemminki, Börje Ljungberg, Otto Hemminki
Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years. PloS one 17 (1) (2022)
Xinjun Li, Anni I Koskinen, Otto Hemminki, Asta Försti, Jan Sundquist, Kristina Sundquist, Kari Hemminki
Family History of Head and Neck Cancers. Cancers 13 (16) (2021)
Kari Hemminki, Asta Försti, Akseli Hemminki, Börje Ljungberg, Otto Hemminki
Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden. PloS one 16 (6) (2021)
Kari Hemminki, Asta Försti, Richard Houlston, Amit Sud
Epidemiology, genetics and treatment of multiple myeloma and precursor diseases. International journal of cancer 149 (12) (2021)
Guoqiao Zheng, Kristina Sundquist, Jan Sundquist, Tianhui Chen, Asta Försti, Akseli E Hemminki, Vaclav Liska, Kari Hemminki
Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary Cancers. Clinical epidemiology 13 (2021)
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli E Hemminki, Xinjun Li
Familial Risks and Proportions Describing Population Landscape of Familial Cancer. Cancers 13 (17) (2021)
Guoqiao Zheng, Kristina Sundquist, Jan Sundquist, Tianhui Chen, Asta Försti, Akseli E Hemminki, Kari Hemminki
Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer. Clinical epidemiology 13 (2021)
Kari Hemminki, Asta Försti, Akseli Hemminki
Survival in colon and rectal cancers in Finland and Sweden through 50 years. BMJ open gastroenterology 8 (1) (2021)
Xinjun Li, Kristina Sundquist, Jan Sundquist, Asta Försti, Kari Hemminki
Family history of any cancer for childhood leukemia patients in Sweden. EJHaem 2 (3) (2021)
Charlie N Saunders, Subhayan Chattopadhyay, Stefanie Huhn, Niels Weinhold, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Stefano Landi, Hartmut Goldschmidt, Paolo Milani, Giampaolo Merlini, Dorota Rowcieno, Philip Hawkins, Ute Hegenbart, Giovanni Palladini, Ashutosh Wechalekar, Stefan O Schönland, Asta Försti, Richard Houlston, Kari Hemminki
Search for AL amyloidosis risk factors using Mendelian randomization. Blood advances 5 (13) (2021)
Guoqiao Zheng, Subhayan Chattopadhyay, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli Hemminki, Kari Hemminki
Association between tumor characteristics and second primary cancers with cutaneous melanoma survival: A nationwide cohort study. Pigment cell & melanoma research 33 (4) (2020)
Kari Hemminki, Aayushi Srivastava, Sivaramakrishna Rachakonda, Obul Bandapalli, Eduardo Nagore, Akseli Hemminki, Rajiv Kumar
Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example. Hereditary cancer in clinical practice 18 (2020)
Guoqiao Zheng, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli E Hemminki, Kari Hemminki
Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor. Cancer medicine 9 (21) (2020)
Amit Sud, Hauke Thomsen, Giulia Orlando, Asta Försti, Philip J Law, Peter Broderick, Rosie Cooke, Fadi Hariri, Tomi Pastinen, Douglas F Easton, Paul David Peter Pharoah, Alison M Dunning, Julian Peto, Frederico Canzian, Rosalind A Eeles, ZSofia Kote-Jarai, Kenneth Muir, Nora Pashayan, Daniele Campa, null null, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Elke Pogge von Strandmann, Anthony J Swerdlow, Nicholas Orr, Andreas Engert, Kari Hemminki, Richard S Houlston
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma. Blood 132 (19) (2018)
Guoqiao Zheng, Akseli E Hemminki, Asta Försti, Jan Sundquist, Kristina Sundquist, Kari Hemminki
Second primary cancer after female breast cancer: Familial risks and cause of death. Cancer medicine 8 (1) (2018)
Kari Hemminki, Otto Hemminki, Asta Försti, Kristina Sundquist, Jan Sundquist, Xinjun Li
Familial risks in urolithiasis in the population of Sweden. BJU international 121 (3) (2018)
Matias Riihimäki, Hauke Thomsen, Kristina Sundquist, Jan Sundquist, Kari Hemminki
Clinical landscape of cancer metastases. Cancer medicine 7 (11) (2018)
Subhayan Chattopadhyay, Guoqiao Zheng, Otto Hemminki, Asta Försti, Kristina Sundquist, Kari Hemminki
Prostate cancer survivors: Risk and mortality in second primary cancers. Cancer medicine 7 (11) (2018)